Trial Profile
STUDY OF THE TOLERANCE OF SODIUM DIVALPROATE (DEPAKOTE) IN ADOLESCENTS IN MANIC, MIXED OR HYPOMANIC EPISODES OF BIPOLAR DISORDER.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Jan 2011
Price :
$35
*
At a glance
- Drugs Valproate semisodium (Primary)
- Indications Bipolar disorders
- Focus Adverse reactions
- Acronyms ADOKOT
- Sponsors Sanofi
- 19 Sep 2006 New trial record.